Last updated on February 2019

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin


Brief description of study

The main purpose of this study is to compare how long subjects with esophageal cancer live overall or live without disease progression after receiving nivolumab and ipilimumab or nivolumab combined with fluorouracil plus cisplatin versus fluorouracil plus cisplatin

Clinical Study Identifier: NCT03143153

Contact Investigators or Research Sites near you

Start Over

Local Institution

Bunkyo-ku, Japan
3.75miles
  Connect »

Local Institution

Yokohama-shi, Japan
3.94miles
  Connect »

Local Institution

Sagamihara-shi, Japan
5.0miles
  Connect »

Local Institution

Kawasaki-shi, Japan
9.27miles
  Connect »

Local Institution

Isehara, Japan
9.75miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.